Key result
Cardiac sarcoidosis affects ~25% of systemic cases, presenting with conduction abnormalities, ventricular arrhythmias, or HF.
Why the study?
Cardiac sarcoidosis is a rare, complex disease with up to 25% occurrence in patients with sarcoidosis in other organs, requiring updated synthesis of current knowledge and identification of key unanswered questions.
Cardiac sarcoidosis is a rare, complex disease presenting with conduction abnormalities, ventricular arrhythmias, or heart failure, requiring interdisciplinary, multicenter research collaborations.
May warrant cardiac screening in systemic sarcoidosis; leaves open optimal management strategies pending multicenter collaborations.
Cardiac sarcoidosis can occur in up to 25% of patients with sarcoidosis in other organ systems and may present with conduction abnormalities, ventricular arrhythmias, or heart failure. This review will summarize the state of current knowledge and key questions that remain to be answered. Because cardiac sarcoidosis is a rare, complex disease, the most meaningful research will include interdisciplinary, multicenter collaborations.
No takes yet. Share an insight, caveat, or question.
Kron et al. (2014) conducted a review in Cardiac sarcoidosis. Cardiac sarcoidosis occurs in up to 25% of patients with systemic sarcoidosis and presents with conduction abnormalities, ventricular arrhythmias, or heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: